Allergan Inc. (NYSE:AGN), the maker of the Botox wrinkle treatment, is being targeted for a takeover by Valeant Pharmaceuticals International Inc. (VRX) with Pershing Square Capital Management LP after rebuffing merger efforts for more than a year. Allergan, Inc. (NYSE:AGN) shares after opening at $134.28 moved to $142.00 on last trade day and at the end of the day closed at $142.00. Company price to sales ratio in past twelve months was calculated as 6.74 and price to cash ratio as 11.64. Allergan, Inc. (NYSE:AGN) showed a positive weekly performance of 17.46%.
Investment fund, The Carlyle Group LP (NASDAQ:CG) has committed an investment to the sub-Saharan African region. The US-based fund manager has already raised USD698 million, reported Ventures Africa. The Carlyle Group LP (NASDAQ:CG) shares advanced 1.61% in last trading session and ended the day on $33.99. CG return on equity ratio is recorded as 18.20% and its return on assets is 0.40%. The Carlyle Group LP (NASDAQ:CG) yearly performance is 10.72%.
Sarepta Therapeutics Inc. (NASDAQ:SRPT) released a statement Monday, April 21st, that it had received guidance from the Food and Drug Administration that it could resubmit for regulatory approval of its Duchenne muscular dystrophy drug eteplirsen before finishing a larger, confirmatory clinical trial. Sarepta Therapeutics Inc. (NASDAQ:SRPT) shares moved up 39.26% in last trading session and was closed at $33.98, while trading in range of $33.57 – $40.00. Sarepta Therapeutics Inc. (NASDAQ:SRPT) year to date (YTD) performance is 66.81%.
The fast-food giant McDonald’s Corporation (NYSE:MCD) is expected to report first-quarter earnings of $1.24 a share, compared with $1.26 a share in the year-ago period, according to analysts surveyed by FactSet. McDonald’s Corporation (NYSE:MCD) weekly performance is 0.38%. On last trading day company shares ended up $99.67. McDonald’s Corporation (NYSE:MCD) distance from 50-day simple moving average (SMA50) is 3.19%. Analysts mean target price for the company is $104.07.